Proteins and Peptides

12 May 2008 Affymax and Takeda Announce Long-Term Hematide Safety and Effectiveness Data from Phase 2 Clinical Trials in Chronic Kidney Disease Patients with Anemia
12 May 2008 Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
08 May 2008 OrthoLogic Announces Positive Safety Data for Initial AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
08 May 2008 LFB Biotechnologies and GTC Biotherapeutics to collaborate on rhAAT program
07 May 2008 Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics; Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing
06 May 2008 Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
06 May 2008 Omigard(TM) Phase III Pivotal Registration Study Enrollment Completed
06 May 2008 Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
05 May 2008 Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze(TM) for Hereditary Angioedema
02 May 2008 Discovery Labs Receives an Approvable Letter from FDA for Surfaxin(R) for RDS
01 May 2008 Allon data demonstrate potential of AL-309 as a new neuropathy treatment
01 May 2008 Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients with Relapsed Solid Tumors
30 Apr 2008 Orexo reports positive results from phase I study for OX19
30 Apr 2008 ZymoGenetics Presents Positive Results from RECOTHROM(TM) Thrombin, topical (Recombinant) Spray Study in Burn Patients
29 Apr 2008 FDA Approves Second Improvement to Unigene's Calcitonin Manufacturing Process
29 Apr 2008 Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
29 Apr 2008 Orexo reports positive results from phase I study for OX19
28 Apr 2008 Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
24 Apr 2008 Ad Hoc: Jerini AG -- FDA Issues Not Approvable Letter for Icatibant in the Treatment of HAE
24 Apr 2008 Dyax Corp. and Cubist Pharmaceuticals, Inc. Sign Development and Commercialization Agreement for DX-88 Surgical Indications
24 Apr 2008 Shire enhances its orphan drug pipeline with the acquisition of a new clinical candidate for Metachromatic Leukodystrophy
24 Apr 2008 Biolex Therapeutics Researchers Present Locteron® Phase 2a Hepatitis C Trial Results at EASL Conference
24 Apr 2008 Jerini Receives Positive CHMP Opinion Recommending European Approval for Icatibant in the Treatment of HAE; FDA Issues Not Approvable Letter
23 Apr 2008 Cytheris Announces New Phase I Study of Interleukin-7 As Immunotherapy In Treatment of Bone Marrow or Peripheral Blood Stem Cell Transplant Patients
23 Apr 2008 Stem Cell Therapeutics Corp. Receives "May Proceed" From FDA for Its Phase IIb Clinical Stroke Trial and IND

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top